Lycopene Does Not Affect Prostate-Specific Antigen in Men with Non-Metastatic Prostate Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA A Cancer J Clin. 2019;69(1):7–34. doi:https://doi.org/10.3322/caac.21551
   PubMed Web of Science ®Google Scholar
• . WCRWHOpCI.World Cancer Report 2014. World Health Organization. 2014. pp. Chapter 5.11. ISBN 9283204298.
   Google Scholar
• Dahan K, Fennal M, Kumar NB. Lycopene in the prevention of prostate cancer. J Soc Integr Oncol. 2008;6(1):29–36.
   PubMedGoogle Scholar
• Story EN, Kopec RE, Schwartz SJ, Harris GK. An update on the health effects of tomato lycopene. Annu Rev Food Sci Technol. 2010;1:189–210. doi:https://doi.org/10.1146/annurev.food.102308.124120
   PubMed Web of Science ®Google Scholar
• Ilic D, Forbes KM, Hassed C. Lycopene for the prevention of prostate cancer. Cochrane Datab Systemat Rev. (Online). 2011;(11).
   Google Scholar
• Stahl W, Sies H. Lycopene: a biologically important carotenoid for humans? Arch Biochem Biophys. 1996;336(1):1–9. doi:https://doi.org/10.1006/abbi.1996.0525
   PubMed Web of Science ®Google Scholar
• Erdman JW, Ford NA, Lindshield BL. Lindshield BLJAob, biophysics. Are the health attributes of lycopene related to its antioxidant function? Arch Biochem Biophys. 2009;483(2):229–35. doi:https://doi.org/10.1016/j.abb.2008.10.022
   PubMed Web of Science ®Google Scholar
• Abrahamsson P-A, Lilja H, Oesterling JE. Molecular forms of serum prostate-specific antigen: the clinical value of percent free prostate-specific antigen. Urol Clin North Am. 1997;24(2):353–65. doi:https://doi.org/10.1016/S0094-0143(05)70382-7
   PubMed Web of Science ®Google Scholar
• Filella X, Fernández-Galan E, Fernández Bonifacio R, Foj L. Emerging biomarkers in the diagnosis of prostate cancer. Pharmgenomics Pers Med. 2018;11:83–94. doi:https://doi.org/10.2147/PGPM.S136026
   PubMed Web of Science ®Google Scholar
• Lu QY, Hung JC, Heber D, Go VL, Reuter VE, Cordon-Cardo C, Scher HI, Marshall JR, Zhang ZF. Inverse associations between plasma lycopene and other carotenoids and prostate cancer. Cancer Epidemiol Biomarkers Prev. 2001;10(7):749–56.
   PubMed Web of Science ®Google Scholar
• World Cancer Research Fund. Food n, physical activity and the prevention of cancer: a global perspective. Washington DC: AICR; 2007.
   Google Scholar
• World Cancer Research Fund International/American Institute for Cancer Research Continuous Update Project Report: Diet N, Physical Activity, and Prostate Cancer. 2018. Available from: www.wcrf.org/sites/default/files/Prostate-cancer-report.pdf.
   Google Scholar
• Kucuk O, Sarkar FH, Sakr W, Djuric Z, Pollak MN. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomark Prevent. 2001;10(8):861–8.
   PubMed Web of Science ®Google Scholar
• Kucuk O, Sarkar FH, Sakr W, Khachik F, Djuric Z, Banerjee M, Pollak MN, Bertram JS, Wood DP. Lycopene in the treatment of prostate cancer. Pure Appl Chem. 2002;74(8):1443–50. doi:https://doi.org/10.1351/pac200274081443
   Web of Science ®Google Scholar
• Paur I, Lilleby W, Bøhn SK, Hulander E, Klein W, Vlatkovic L, Axcrona K, Bolstad N, Bjøro T, Laake P, et al. Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA. Clin Nutr. 2017;36(3):672–9. doi:https://doi.org/10.1016/j.clnu.2016.06.014
   PubMed Web of Science ®Google Scholar
• Bunker CH, McDonald AC, Evans RW, De La Rosa N, Boumosleh JM, Patrick AL. A randomized trial of lycopene supplementation in Tobago men with high prostate cancer risk. Nutr Cancer. 2007;57(2):130–7. doi:https://doi.org/10.1080/01635580701274046
   PubMed Web of Science ®Google Scholar
• Kumar NB, Besterman-Dahan K, Kang L, Pow-Sang J, Xu P, et al. Results of a randomized clinical trial of the action of several doses of lycopene in localized prostate cancer: administration prior to radical prostatectomy. Clinical Medicine Urology. 2008;1:1–14. [electronic resource].
   PubMedGoogle Scholar
• Schwarz S, ObermüLler-Jevic UC, Hellmis E, Koch W, Jacobi Gnther, Biesalski Hans-Konrad. Lycopene inhibits disease progression in patients with benign prostate hyperplasia. The Journal of Nutrition. 2008;138((1):49–53. doi:https://doi.org/10.1093/jn/138.1.49
   PubMed Web of Science ®Google Scholar
• Gann PH, Deaton RJ, Rueter EE, van Breemen RB, Nonn L, Macias V, Han M, Ananthanarayanan V. A phase II randomized trial of lycopene-rich tomato extract among men with high-grade prostatic intraepithelial neoplasia. Nutr Cancer. 2015;67:1104–12.
   Google Scholar
• Liberati Alessandro, Altman DouglasG, Tetzlaff Jennifer, Mulrow Cynthia, Gøtzsche PeterC, Ioannidis JohnPA, Clarke Mike, Devereaux PJ, Kleijnen Jos, Moher David. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700 doi:https://doi.org/10.1136/bmj.b2700
   PubMed Web of Science ®Google Scholar
• Higgins 2011. Higgins JPT GSeChfsroi VuMTCC, 2011. http://www.cochrane-handbook.org.
   Google Scholar
• Hozo StelaPudar, Djulbegovic Benjamin, Hozo Iztok. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5(1):13. doi:https://doi.org/10.1186/1471-2288-5-13
   PubMedGoogle Scholar
• Fedorov SGGDvGd-d-c, Russia.
   Google Scholar
• Brondani LA, Assmann TS, de Souza BM, Boucas AP, Canani LH, Crispim D. Meta-analysis reveals the association of common variants in the uncoupling protein (UCP) 1-3 genes with body mass index variability. PLoS One. 2014;9(5):e96411 doi:https://doi.org/10.1371/journal.pone.0096411
   PubMed Web of Science ®Google Scholar
• Zahedi Hoda, Djalalinia Shirin, Sadeghi Omid, Asayesh Hamid, Noroozi Mehdi, Gorabi ArmitaMahdavi, Mohammadi Rasool, Qorbani Mostafa. Dietary inflammatory potential score and risk of breast cancer: systematic review and meta-analysis. Clin Breast Cancer. 2018;18(4):e561–e70. doi:https://doi.org/10.1016/j.clbc.2018.01.007
   PubMed Web of Science ®Google Scholar
• Ansari MS, Gupta NP. Lycopene: A novel drug therapy in hormone refractory metastatic prostate cancer. Urologic Oncol: Sem Orig Investig. 2004;22(5):415–20. doi:https://doi.org/10.1016/S1078-1439(04)00122-X
   PubMed Web of Science ®Google Scholar
• Barber NJ, Zhang X, Zhu G, Pramanik R, Barber JA, Martin FL, Morris JDH, Muir GH. Lycopene inhibits DNA synthesis in primary prostate epithelial cells in vitro and its administration is associated with a reduced prostate-specific antigen velocity in a phase II clinical study. Prostate Cancer Prostatic Dis. 2006;9(4):407–13. doi:https://doi.org/10.1038/sj.pcan.4500895
   PubMed Web of Science ®Google Scholar
• Bowen Phyllis, Chen Longwen, Stacewicz-Sapuntzakis Maria, Duncan Claudine, Sharifi Roohollah, Ghosh Luna, Kim Hyung-Sook, Christov-Tzelkov Konstantin, Breemen RichardVan. Tomato sauce supplementation and prostate cancer: Lycopene accumulation and modulation of biomarkers of carcinogenesis. Exp Biol Med (Maywood)). 2002;227(10):886–93. doi:https://doi.org/10.1177/153537020222701008
   PubMed Web of Science ®Google Scholar
• Clark PeterE, Hall MCraig, Borden LesterS, Miller AntoniusA, Hu JenniferJ, Lee WRobert, Stindt Diana, D'Agostino Ralph, Lovato James, Harmon Michelle, et al. Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy. Urology. 2006;67(6):1257–61. doi:https://doi.org/10.1016/j.urology.2005.12.035
   PubMed Web of Science ®Google Scholar
• Edinger MS, Koff WJ. Effect of the consumption of tomato paste on plasma prostate-specific antigen levels in patients with benign prostate hyperplasia. Braz J Med Biol Res. 2006;39(8):1115–9. doi:https://doi.org/10.1590/s0100-879x2006000800014
   PubMed Web of Science ®Google Scholar
• Jatoi Aminah, Burch Patrick, Hillman David, Vanyo JoanneM, Dakhil Shaker, Nikcevich Daniel, Rowland Kendrith, Morton Roscoe, Flynn PatrickJ, Young Charles, North Central Cancer Treatment Group, et al. A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from The North Central Cancer Treatment Group. Urology. 2007;69(2):289–94. doi:https://doi.org/10.1016/j.urology.2006.10.019
   PubMed Web of Science ®Google Scholar
• Schwenke C, Ubrig B, Thurmann P, Eggersmann C, Roth S. Lycopene for advanced hormone refractory prostate cancer: a prospective, open phase II pilot study. J Urol. 2009;181(3):1098–103. doi:https://doi.org/10.1016/j.juro.2008.11.012
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang Q, Barber N, Chen X. Effect of lycopene on androgen receptor and prostate-specific antigen velocity. Chin Med J (Engl)). 2010;123(16):2231–6.
   PubMed Web of Science ®Google Scholar
• Kim Hyung-Sook, Bowen Phyllis, Chen Longwen, Duncan Claudine, Ghosh Luna, Sharifi Roohollah, Christov Konstantin. Effects of tomato sauce consumption on apoptotic cell death in prostate benign hyperplasia and carcinoma. Nutr Cancer. 2003;47(1):40–7. 47doi:https://doi.org/10.1207/s15327914nc4701_5
   PubMed Web of Science ®Google Scholar
• Lane JAthene, Er Vanessa, Avery KerryNL, Horwood Jeremy, Cantwell Marie, Caro GemaP, Crozier Alan, Smith GeorgeDavey, Donovan JennyL, Down Liz, et al. Prodiet: A Phase II randomized placebo-controlled trial of green tea catechins and lycopene in men at increased risk of prostate cancer. Cancer Prev Res. 2018;11(11):687–96. doi:https://doi.org/10.1158/1940-6207.CAPR-18-0147
   PubMed Web of Science ®Google Scholar
• Beynon RA, Richmond RC, Santos Ferreira DL, Ness AR, May M, Smith GD, Vincent EE, Adams C, Ala-Korpela M, Würtz P, PRACTICAL consortium, et al. Investigating the effects of lycopene and green tea on the metabolome of men at risk of prostate cancer: The ProDiet randomised controlled trial. Int J Cancer. 2019;144(8):1918–28. doi:https://doi.org/10.1002/ijc.31929
   PubMed Web of Science ®Google Scholar
• Biernacka KM, Holly JMP, Martin RM, Frankow A, Bull CJ, Hamdy FC, Donovan JL, Neal DE, Metcalfe C, Lane A, et al. Effect of green tea and lycopene on the insulin-like growth factor system: the ProDiet randomized controlled trial. Eur J Cancer Prev. 2019;28(6):569–75. doi:https://doi.org/10.1097/CEJ.0000000000000502
   PubMed Web of Science ®Google Scholar
• Grainger EM, Moran NE, Francis DM, Schwartz SJ, Wan L, Thomas-Ahner J, Kopec RE, Riedl KM, Young GS, Abaza R, et al. A novel tomato-soy juice induces a dose-response increase in urinary and plasma phytochemical biomarkers in men with prostate cancer. Journal of Nutrition. 2019;149(1):26–35. doi:https://doi.org/10.1093/jn/nxy232
   PubMed Web of Science ®Google Scholar
• Chan JM, Weinberg V, Magbanua MJ, Sosa E, Simko J, Shinohara K, Federman S, Mattie M, Hughes-Fulford M, Haqq C, et al. Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer. Cancer Causes Control. 2011;22(1):141–50. doi:https://doi.org/10.1007/s10552-010-9684-5
   PubMed Web of Science ®Google Scholar
• Gontero P, Marra G, Soria F, Oderda M, Zitella A, Baratta F, Chiorino G, Gregnanin I, Daniele L, Cattel L, et al. A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"? Prostate. 2015;75(11):1177–86. doi:https://doi.org/10.1002/pros.22999
   PubMed Web of Science ®Google Scholar
• Morgia G, Cimino S, Favilla V, Russo GI, Squadrito F, Mucciardi G, Masieri L, Minutoli L, Grosso G, Castelli T, et al. Effects of Serenoa Repens, Selenium and Lycopene (Profluss®) on chronic inflammation associated with Benign Prostatic Hyperplasia: Results of "FLOG" (Flogosis and Profluss in Prostatic and Genital Disease), a multicentre italian study. Int Braz J Urol. 2013;39(2):214–21. doi:https://doi.org/10.1590/S1677-5538.IBJU.2013.02.10
   PubMed Web of Science ®Google Scholar
• Morgia G, Micali A, Rinaldi M, Irrera N, Marini H, Puzzolo D, Pisani A, Privitera S, Russo G, Cimino S, et al. Survivin and NAIP in human benign prostatic hyperplasia: Protective role of the association of Serenoa repens, lycopene and selenium from the randomized clinical study. IJMS. 2017;18(3):680. doi:https://doi.org/10.3390/ijms18030680
   Web of Science ®Google Scholar
• Schröder FH, Roobol MJ, Boevé ER, de Mutsert R, Zuijdgeest-van Leeuwen SD, Kersten I, Wildhagen MF, van Helvoort A. Randomized, double-blind, placebo-controlled crossover study in men with prostate cancer and rising PSA: effectiveness of a dietary supplement. Eur Urol. 2005;48(6):922–30. discussion 30-1. doi:https://doi.org/10.1016/j.eururo.2005.08.005
   PubMed Web of Science ®Google Scholar
• Sandu MR, Ferreira DLS, Richmond R, Hackshaw-McGeagh L, Beynon R, et al. Investigating the effects of dietary and physical activity interventions on the metabolome of men with prostate cancer: The PrEvENT randomised controlled trial. Br J Cancer. 2018;119(1):35–6.
   Google Scholar
• van Breemen RB, Sharifi R, Viana M, Pajkovic N, Zhu D, Yuan L, Yang Y, Bowen PE, Stacewicz-Sapuntzakis M. Antioxidant effects of lycopene in African American men with prostate cancer or benign prostate hyperplasia: A randomized, controlled trial. Cancer Prevention Research. 2011;4(5):711–8. doi:https://doi.org/10.1158/1940-6207.CAPR-10-0288
   PubMed Web of Science ®Google Scholar
• Talvas J, Caris-Veyrat C, Guy L, Rambeau M, Lyan B, Minet-Quinard R, Lobaccaro J-MA, Vasson M-P, Georgé S, Mazur A, et al. Differential effects of lycopene consumed in tomato paste and lycopene in the form of a purified extract on target genes of cancer prostatic cells. Am J Clin Nutr. 2010;91(6):1716–24. doi:https://doi.org/10.3945/ajcn.2009.28666
   PubMed Web of Science ®Google Scholar
• Chen L, Stacewicz-Sapuntzakis M, Duncan C, Sharifi R, Ghosh L, Breemen R. v, Ashton D, Bowen PE. Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. Journal of the National Cancer Institute. 2001;93(24):1872–9. doi:https://doi.org/10.1093/jnci/93.24.1872
   PubMedGoogle Scholar
• Mohanty NK, Saxena S, Singh UP, Goyal NK, Arora RP. Lycopene as a chemopreventive agent in the treatment of high-grade prostate intraepithelial neoplasia. Urol Oncol. 2005;23(6):383–5. doi:https://doi.org/10.1016/j.urolonc.2005.05.012
   PubMed Web of Science ®Google Scholar
• Grainger E, Schwartz S, Wang S, Unlu N, Boileau T, Ferketich A, Monk JP, Gong M, Bahnson R, DeGroff V, et al. A combination of tomato and soy products for men with recurring prostate cancer and rising prostate specific antigen. Nutrition & Cancer. 2008;60(2):145–54. doi:https://doi.org/10.1080/01635580701621338
   PubMed Web of Science ®Google Scholar
• Ansari MS, Gupta NP. A comparison of lycopene and orchidectomy vs orchidectomy alone in the management of advanced prostate cancer. BJU International. 2003;92(4):375–8. doi:https://doi.org/10.1046/j.1464-410X.2003.04370.x
   PubMed Web of Science ®Google Scholar
• Stacewicz-Sapuntzakis M, Bowen PE. Role of lycopene and tomato products in prostate health. Biochim Biophys Acta. 2005;1740(2):202–5. doi:https://doi.org/10.1016/j.bbadis.2005.02.004
   PubMed Web of Science ®Google Scholar
• Vaishampayan U, Hussain M, Banerjee M, Seren S, Sarkar FH, Fontana J, Forman JD, Cher ML, Powell I, Pontes J, et al. Lycopene and soy isoflavones in the treatment of prostate cancer. Nutr Cancer. 2007;59(1):1–7. doi:https://doi.org/10.1080/01635580701413934
   PubMed Web of Science ®Google Scholar
• Kucuk O, Sarkar FH, Djuric Z, Sakr W, Pollak MN, Khachik F, Banerjee M, Bertram JS, Wood DP. Effects of lycopene supplementation in patients with localized prostate cancer. Exp Biol Med (Maywood). 2002;227(10):881–5. doi:https://doi.org/10.1177/153537020222701007
   PubMed Web of Science ®Google Scholar
• Buckner CA, Lafrenie RM, Denommee JA, Caswell JM, Want DA. Complementary and alternative medicine use in patients before and after a cancer diagnosis. Curr Oncol. 2018;25(4):e275–e81. doi:https://doi.org/10.3747/co.25.3884
   PubMed Web of Science ®Google Scholar
• Bishop FL, Rea A, Lewith H, Chan YK, Saville J, Prescott P, von Elm E, Lewith GT. Complementary medicine use by men with prostate cancer: a systematic review of prevalence studies. Prostate Cancer Prostatic Dis. 2011;14(1):1–13. doi:https://doi.org/10.1038/pcan.2010.38
   PubMed Web of Science ®Google Scholar
• Chan JM, Elkin EP, Silva SJ, Broering JM, Latini DM, Carroll PR. Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer. Urology. 2005;66(6):1223–8. doi:https://doi.org/10.1016/j.urology.2005.06.003
   PubMed Web of Science ®Google Scholar
• Haseen F, Cantwell MM, O'Sullivan JM, Murray LJ. Is there a benefit from lycopene supplementation in men with prostate cancer? A systematic review. Prostate Cancer Prostatic Dis. 2009;12(4):325–32. doi:https://doi.org/10.1038/pcan.2009.38
   PubMed Web of Science ®Google Scholar
• Etminan M, Takkouche B, Caamano-Isorna F. The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the. Amer Soc Prevent Oncol. 2004;13(3):340–5.
   Google Scholar
• Ilic D, Misso M. Lycopene for the prevention and treatment of benign prostatic hyperplasia and prostate cancer: a systematic review. Maturitas. 2012;72(4):269–76. doi:https://doi.org/10.1016/j.maturitas.2012.04.014
   PubMed Web of Science ®Google Scholar
• Reed D, Raina K, Agarwal RJN. Nutraceuticals in prostate cancer therapeutic strategies and their neo-adjuvant use in diverse populations. NPJ Precis Oncol. 2018;2(1):1–20.
   Google Scholar
• Jiang L-N, Liu Y-B, Li B-H. Lycopene exerts anti-inflammatory effect to inhibit prostate cancer progression. Asian J Androl. 2018;21(1):80–5.
   Web of Science ®Google Scholar
• McDonald AC, Vira MA, Vidal AC, Gan W, Freedland SJ, Taioli E. Association between systemic inflammatory markers and serum prostate-specific antigen in men without prostatic disease - the 2001-2008 National Health and Nutrition Examination Survey. Prostate. 2014;74(5):561–7. doi:https://doi.org/10.1002/pros.22782
   PubMed Web of Science ®Google Scholar
• Witherington R, Janosko J, Borosso DCС. FALK10 S, ROUNDER JJBJU. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. 1998;81:730–4. doi:https://doi.org/10.1046/j.1464-410x.1998.00630.x
   Google Scholar
• Meyer F, Galan P, Douville P, Bairati I, Kegle P, et al. Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU. VI. MAX trial. Int J Cancer. 2005;116(2):182–6.
   Google Scholar
• De Marzo AM, Coffey DS, Nelson WGJU. New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia. Urology. 1999;53(3 Suppl 3a):29–40. doi:https://doi.org/10.1016/S0090-4295(98)00536-6
   PubMed Web of Science ®Google Scholar
• Porrini M, Riso PJTJ. What are typical lycopene intakes? J Nutr. 2005;135(8):2042S–5S. doi:https://doi.org/10.1093/jn/135.8.2042S
   PubMed Web of Science ®Google Scholar
• Wang Y, Cui R, Xiao Y, Fang J, Xu Q. Effect of carotene and lycopene on the risk of prostate cancer: a systematic review and dose-response meta-analysis of observational studies. PloS One. 2015;10(9):e0137427 doi:https://doi.org/10.1371/journal.pone.0137427
   PubMed Web of Science ®Google Scholar
• Matsushima-Nishiwaki R, Shidoji Y, Nishiwaki S, Yamada T, Moriwaki H, Muto Y. Suppression by carotenoids of microcystin-induced morphological changes in mouse hepatocytes . Lipids. 1995;30(11):1029–34. doi:https://doi.org/10.1007/BF02536288
   PubMed Web of Science ®Google Scholar
• Karas M, Amir H, Fishman D, Danilenko M, Segal S, Nahum A, Koifmann A, Giat Y, Levy J, Sharoni Y, et al. Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. Nutr Cancer. 2000;36(1):101–11. doi:https://doi.org/10.1207/S15327914NC3601_14
   PubMed Web of Science ®Google Scholar
• Giovannucci E, Rimm EB, Liu Y, Stampfer MJ, WCJJotNCI Willett. A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst. 2002;94(5):391–8. doi:https://doi.org/10.1093/jnci/94.5.391
   Google Scholar
• Hróbjartsson AJJoce. What are the main methodological problems in the estimation of placebo effects? J Clin Epidemiol. 2002;55(5):430–5. doi:https://doi.org/10.1016/s0895-4356(01)00496-6
   PubMed Web of Science ®Google Scholar
• Krogsbøll LT, Hróbjartsson A, Gøtzsche PC. Spontaneous improvement in randomised clinical trials: meta-analysis of three-armed trials comparing no treatment, placebo and active intervention. BMC Med Res Methodol. 2009;9:1. doi:https://doi.org/10.1186/1471-2288-9-1
   PubMed Web of Science ®Google Scholar
• Wang X-D. Lycopene metabolism and its biological significance. Am J Clin Nutr. 2012;96(5):1214S–22S. doi:https://doi.org/10.3945/ajcn.111.032359
   PubMed Web of Science ®Google Scholar